Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Fusion Pharmaceuticals In...

    NASDAQ: FUSN · Real-Time Price · USD
    21.55
    0.03 (0.14%)
    At close: Jun 03, 2024, 10:00 PM

    Fusion Pharmaceuticals Statistics

    Share Statistics

    Fusion Pharmaceuticals has 85.06M shares outstanding. The number of shares has increased by 0% in one year.

    Shares Outstanding

    n/a
    		 85.06M

    Shares Change (YoY)

    n/a
    		 0%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 61.58M

    Failed to Deliver (FTD) Shares

    n/a
    		 600

    FTD / Avg. Volume

    n/a
    		 0.03%

    Short Selling Information

    Short Interest

    n/a
    		 n/a

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 n/a

    Short Ratio (days to cover)

    n/a
    		 n/a

    Valuation Ratios

    The PE ratio is -6.64 and the forward PE ratio is null. Fusion Pharmaceuticals's PEG ratio is 0.24.

    PE Ratio

    n/a
    		 -6.64

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 304.9

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 2.83

    P/FCF Ratio

    n/a
    		 -7.36

    PEG Ratio

    n/a
    		 0.24
    Financial Ratio History

    Enterprise Valuation

    Fusion Pharmaceuticals has an Enterprise Value (EV) of 618.94M.

    EV / Sales

    n/a
    		 299.29

    EV / EBITDA

    n/a
    		 -6.32

    EV / EBIT

    n/a
    		 -7.57

    EV / FCF

    n/a
    		 -7.22

    Financial Position

    The company has a current ratio of 15.01, with a Debt / Equity ratio of 0.18.

    Current Ratio

    n/a
    		 15.01

    Quick Ratio

    n/a
    		 15.01

    Debt / Equity

    n/a
    		 0.18

    Debt / EBITDA

    n/a
    		 -0.51

    Debt / FCF

    n/a
    		 -0.59

    Interest Coverage

    n/a
    		 -19.21

    Financial Efficiency

    Return on Equity is -42.65% and Return on Invested Capital is -38.28%.

    Return on Equity

    n/a
    		 -42.65%

    Return on Assets

    n/a
    		 -33.2%

    Return on Invested Capital

    n/a
    		 -38.28%

    Revenue Per Employee

    n/a
    		 $20,475.25

    Profits Per Employee

    n/a
    		 $-939,574.26

    Employee Count

    n/a
    		 101

    Asset Turnover

    n/a
    		 0.01

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 787K

    Effective Tax Rate

    n/a
    		 -0.84%

    Stock Price Statistics

    The stock price has increased by 0.7% in the last 52 weeks. The beta is -0.69, so Fusion Pharmaceuticals's price volatility has been lower than the market average.

    Beta

    n/a
    		 -0.69

    52-Week Price Change

    n/a
    		 0.7%

    50-Day Moving Average

    n/a
    		 21.4

    200-Day Moving Average

    n/a
    		 10.51

    Relative Strength Index (RSI)

    n/a
    		 69.06

    Average Volume (20 Days)

    n/a
    		 1,965,984

    Income Statement

    In the last 12 months, Fusion Pharmaceuticals had revenue of 2.07M and earned -94.9M in profits. Earnings per share was -1.45.

    Revenue

    n/a
    		 2.07M

    Gross Profit

    n/a
    		 723K

    Operating Income

    n/a
    		 -99.23M

    Net Income

    n/a
    		 -94.9M

    EBITDA

    n/a
    		 -97.89M

    EBIT

    n/a
    		 -88.94M

    Earnings Per Share (EPS)

    n/a
    		 -1.45
    Full Income Statement

    Balance Sheet

    The company has 61.92M in cash and 50.33M in debt, giving a net cash position of 11.59M.

    Cash & Cash Equivalents

    n/a
    		 61.92M

    Total Debt

    n/a
    		 50.33M

    Net Cash

    n/a
    		 11.59M

    Retained Earnings

    n/a
    		 -376.76M

    Total Assets

    n/a
    		 323.81M

    Working Capital

    n/a
    		 200.16M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -81.8M and capital expenditures -3.89M, giving a free cash flow of -85.69M.

    Operating Cash Flow

    n/a
    		 -81.8M

    Capital Expenditures

    n/a
    		 -3.89M

    Free Cash Flow

    n/a
    		 -85.69M

    FCF Per Share

    n/a
    		 -1.31
    Full Cash Flow Statement

    Margins

    Gross margin is 34.96%, with operating and profit margins of -4798.45% and -4588.83%.

    Gross Margin

    n/a
    		 34.96%

    Operating Margin

    n/a
    		 -4798.45%

    Pretax Margin

    n/a
    		 -4550.77%

    Profit Margin

    n/a
    		 -4588.83%

    EBITDA Margin

    n/a
    		 -4733.41%

    EBIT Margin

    n/a
    		 -4798.45%

    FCF Margin

    n/a
    		 -4143.71%

    Dividends & Yields

    FUSN does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 -15.05%

    FCF Yield

    n/a
    		 -13.59%
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for FUSN.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 11.39

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist